What If You Can’t Pick Winners in R&D?

Peter Thiel, the contrarian investor, had a favorite question for interviewees: “What important truth do few people agree with you on?” My answer: No one can pick winners in pharma R&D. When I think of the most significant blockbusters in the industry involving novel mechanisms of action (follow-ons are a different story), I see a... Read More